"None of these headwinds can be faced without us bending. From my perspective, this move is a response to those changes, and it demonstrates our ability to be able to meet a challenge - it is important because it is going to continue," he told BioPharmaDispatch. …
Dennis Bastas on Arrotex and creating the largest company by volume in PBS history
July 11, 2019 Latest NewsBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
New partnership expands access to care for Australians with rare cancers
May 19, 2026 - - Latest News -
Sandoz urges faster access as government signals biosimilar consultation
May 19, 2026 - - Latest News -
Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation
May 19, 2026 - - Latest News -
Government sidesteps committee call on CGMs, insulin pumps and GLP‑1 access
May 18, 2026 - - Latest News -
Budget papers signal the work that has already been done on reform proposals
May 18, 2026 - - Latest News -
If the demand is to pay for reform, are these reforms really worth paying for?
May 18, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 15 May
May 15, 2026 - - Podcast